Jean-Paul Coutelier

Prof. Jean-Paul Coutelier

Unit of Experimental Medicine, de Duve Institute, Université Catholique de Louvain, SSS/DDUV – ICP, Av. Hippocrate 75, bte B1.75.02, 1200 Brussels, Belgium
orcid

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
Ndoricyimpaye Ella LarissaNdoricyimpaye Ella Larissa
Ndoricyimpaye Ella Larissa
JSJacques Van Snick
Jacques Van Snick
RRRobert Rutayisire Rutayisire
Robert Rutayisire Rutayisire
EBEmmanuel Bikorimana
Emmanuel Bikorimana
OMOnesphore Majyambere
Onesphore Majyambere
NRNadine Rujeni
Nadine Rujeni
For effective treatments and preventive measures against severe COVID-19, it is essential to determine early markers of disease severity in different populations. We analysed the cytokine kinetics of 129 COVID-19 patients with mild symptoms, 68 severe cases, and 20 healthy controls for the first time in Rwanda. Pro-inflammatory (IFNγ, IL-6, TNFα), Treg (IL-10, TGFβ1, TGFβ3), Th9 (IL-9), Th17 (IL-17), and Th2 (IL-4, IL-13) cytokines, total IgM and IgG, as well as gene expressions of FoxP3, STAT5+, IFNγ-R1, and ROR alpha+, were measured at day 1, day 7, day 14, day 21, and day 28 post-infection. Severe cases showed a significantly stronger increase than mild patients in levels of all cytokines (except IL-9) and all gene expression on day 1 of infection. Some cytokine levels dropped to levels comparable to mild cases at later time points. Further analysis identified IFNγ as a marker of severity throughout the disease course, while TGFβ1, IL-6, and IL-17 were markers of severity only at an early phase. Importantly, this study revealed a striking low IL-9 level and high IFNγ/IL-9 ratio in the plasma of patients who later died compared to mild and severe cases who recovered, suggesting that this could be an important biomarker for predicting the severity of COVID-19 and post-COVID-19 syndrome.

27 March 2022 in Microorganisms
Verified
Journal Article
Open access
PDF file
JMJean d'Amour Mutoni
Jean d'Amour Mutoni
Jean-Paul CoutelierJean-Paul Coutelier
Jean-Paul Coutelier
NRNadine Rujeni
Nadine Rujeni
LMLeon Mutesa
Leon Mutesa
Patrice CaniPatrice Cani
Patrice Cani
Malaria, caused by the Plasmodium species, is an infectious disease responsible for more than 600 thousand deaths and more than 200 million morbidity cases annually. With above 90% of those deaths and cases, sub-Saharan Africa is affected disproportionately. Malaria clinical manifestations range from asymptomatic to simple, mild, and severe disease. External factors such as the gut microbiota and helminthiases have been shown to affect malaria clinical manifestations. However, little is known about whether the gut microbiota has the potential to influence malaria clinical manifestations in humans. Similarly, many previous studies have shown divergent results on the effects of helminths on malaria clinical manifestations. To date, a few studies, mainly murine, have shown the gut microbiota’s capacity to modulate malaria’s prospective risk of infection, transmission, and severity. This short review seeks to summarize recent literature about possible interactions between malaria, helminthiases, and the gut microbiota. The knowledge from this exercise will inform innovation possibilities for future tools, technologies, approaches, and policies around the prevention and management of malaria in endemic countries.

5 November 2008 in Immunology
Verified
Journal Article
Open access
PDF file
GTGaëtan Thirion
Gaëtan Thirion
AFAna Agusti Feliu
Ana Agusti Feliu
Jean-Paul CoutelierJean-Paul Coutelier
Jean-Paul Coutelier
Summary: CD66a (CEACAM1), an adhesion molecule that has regulatory function on T lymphocytes, was found to be expressed on a minority of mouse natural killer (NK) cells, especially in the liver. CD66a expression on NK cells depended on their differentiation stage, with highest levels on immature CD49b−NK cells. Expression of CD66a on NK cells was strongly enhanced by in vitro activation with interleukin‐12 (IL‐12) and IL‐18. However, in vivo NK cell stimulation by infection with lactate dehydrogenase‐elevating virus did not lead to strong CD66a expression, even on activated interferon‐‐γ‐producing NK cells. These results indicate that CD66a expression is differently regulated, depending on the NK cell activation pathway, which may lead to distinct regulatory mechanisms of the functional subpopulations of these cells.

Verified
Journal Article
Open access
PDF file
Ndoricyimpaye Ella LarissaNdoricyimpaye Ella Larissa
Ndoricyimpaye Ella Larissa
JSJacques Van Snick
Jacques Van Snick
Jean de Dieu NIYOYITAJean de Dieu NIYOYITA
Jean de Dieu NIYOYITA
PKPhilbert Kanimba
Philbert Kanimba
Jean Bosco MbonimpaJean Bosco Mbonimpa
Jean Bosco Mbonimpa
NRNadine Rujeni
Nadine Rujeni
The proper control of Plasmodium infection requires a finely balanced immune response. Here, we evaluated the implication of TGF-β1 and TGF-β3 in this process using novel monoclonal antibodies to measure their plasma concentrations in comparison with other cytokines and the expression of FOXP3 mRNA. Plasma cytokine levels were measured in 80 patients with severe anaemic malaria and 186 with a mild presentation using ELISA, and rtPCR was used to measure FOXP3 mRNA expression. While no mature TGF-β isoforms were detected in the plasma, the latent TGF-β1 and TGF-β3 were strongly upregulated in patients with mild malaria and nearly undetected in patients with severe disease. Similar selective upregulation in mild patients was observed for IL-9 and FOXP3 mRNA, while IL-7, IL-10, IL-17, and IL-27, although higher in mild cases, were also detected in severe disease. In contrast, a clearly skewed trend of severe cases towards higher pro-inflammatory (IL-6, IL-13, TNF-α) and Th1 (IFN-γ) responses was observed, which was associated with a higher level of parasitaemia as well as lower IgG and higher IgM responses. Together, these results suggest that the stimulation of regulatory T cells through TGF-β1/TGF-β3 and IL-9 is paramount to an effective and balanced protective immunity in natural human malaria infection.

31 March 2021 in European Journal of Immunology
Verified
Journal Article
Closed access
PDF file
MGMélanie Gaignage
Mélanie Gaignage
CUCatherine Uyttenhove
Catherine Uyttenhove
LJLindsay L. Jones
Lindsay L. Jones
CBChristophe Bourdeaux
Christophe Bourdeaux
PCPaméla Chéou
Paméla Chéou
JSJacques Van Snick
Jacques Van Snick

15 November 2012 in Journal of Virology
Verified
Journal Article
Open access
PDF file
DSDan Su
Dan Su
AMAndrei Musaji
Andrei Musaji
SLSarah Legrain
Sarah Legrain
LDLaurent Detalle
Laurent Detalle
JKJos van der Kaa
Jos van der Kaa
Jean-Paul CoutelierJean-Paul Coutelier
Jean-Paul Coutelier
Previously we demonstrated that antibody-mediated thrombocytopenia is strongly enhanced by lactate dehydrogenase-elevating virus (LDV) infection. Here we report that mice infected with LDV develop a moderate thrombocytopenia, even in the absence of immunoglobulins or Fc receptors. A similar decrease of platelet counts was observed after mouse hepatitis virus infection. LDV-induced type I interferon-independent thrombocytopenia was partly suppressed by treatment with clodronate-containing liposomes. Therefore, we conclude that the thrombocytopenia results from increased phagocytosis of nonopsonized platelets by macrophages.